Brachytherapy (intraluminal radiotherapy) has been in use for more than two decades as a boost after external beam radiation for the definite treatment of esophageal carcinoma. Recent studies have ...shown that brachytherapy as a sole treatment is an effective therapy for the palliation of dysphagia caused by inoperable esophageal carcinoma. In comparison to stent placement, which is currently the most widely used palliative treatment for esophageal cancer, single-dose brachytherapy has been shown to be a more effective but also safer treatment option for palliation of dysphagia. A broader use of brachytherapy for the palliative treatment of dysphagia from esophageal cancer, particularly in younger and female patients that have a shorter tumor length, no metastases, and a good performance score, is therefore warranted. New developments include the use of fractionated doses of brachytherapy and the use of stents that have a radioactive source included.
Full text
Available for:
GEOZS, IJS, IMTLJ, KILJ, KISLJ, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UL, UM, UPCLJ, UPUK
Load filters
No result was selected!
Please select the results that you wish to export.
The search was successfully saved.
Editing
The search could not be saved.
Saved searches can be viewed in the list My searches.
The changes made to the saved search were saved successfully.
Save search
Shelf entry
No result was selected!
Adding material to shelf was successful.
Adding material to shelf was partly successful.
Adding material to shelf failed completely.
It was not necessary to add the material to the shelf.
Please select the results that you want to put on shelf!
On shelf the following records have been successfully added:
On shelf the following records have been successfully added:
